Yael Gozin is a senior director at Pfizer, where she works with clinical development teams across Pfizer’s portfolio, which raised her interests in the use of technology to improve the processes and data quality associated with clinical development and regulatory submissions. Yael provides technical guidance both in designing and implementing innovative AI solutions to automate quality processes and coaching and mentoring of project teams across different therapeutic areas including oncology, innovative pharma, established products, and consumer products. She holds a doctorate from Swiss Federal Institute of Technology, Zurich (ETH Zurich) in organic chemistry and a master’s degree from the Weizmann Institute in organometallic chemistry.